Options for Managing Treatment-Resistant Depression

1. Major depressive disorder (MDD) is characterized by the occurrence for at least 2 weeks of depressed mood and loss of interest in activities that were rather pleasurable in the past. It can be accompanied by which of the following:
2. Treatment-resistant depression (TRD) in MDD can be defined as a minimum of:
3. Which percentage of patients with MDD will achieve remission with pharmacotherapy?
4. Which of the following complementary and alternative options has been found to help improve depressive symptoms?
5. Which of the following would be an appropriate augmenting agent for an elderly patient with a partial response to a maximum dose of citalopram with residual depressive symptoms of low appetite and insomnia?
6. Which of the following agents has an FDA-approved indication for TRD?
7. Which is an example of appropriate augmentation strategy of an antidepressant for a patient with TRD?
8. Which psychotropics are only indicated as augmenting agents when treating TRD?
9. Which of the following nonpharmacologic interventions has demonstrated the greatest efficacy when treating MDD?
10. Which strategy is most appropriate when a patient partially responds to an antidepressant at a medium dose after 10 weeks?
Evaluation Questions
11. Met objective 1:
12. Met objective 2:
13. Met objective 3:
14. Met objective 4:
15. Related to your educational needs:
16. The active learning strategies (questions, cases, discussions) were appropriate and effective learning tools:
17. Avoided commercial bias:
18. How would you rate the overall usefulness of the material presented?
19. How would you rate the quality of the faculty?
20. How would you rate the appropriateness of the examination for this activity?